by Bob von Halle | Mar 12, 2020 | Commentary, Options
It would be senseless in today’s volatile environment to write about individual option trades or flows. By the time anyone read my posts, the market and option prices are likely to have moved significantly, making the information all but worthless. What I would...
by Bob von Halle | Feb 12, 2020 | Commentary, Options
Courtesy of Goldman Sachs, the below chart shows the stunning surge in single name stock option volume as a percent of the underlying normal share volume totaling a record 91%. Since 2006 the closest second place finisher for this percentage has been in the low 60%...
by Bob von Halle | Feb 7, 2020 | Commentary, Options
Just saw the following post courtesy of Trade Alert (www.trade-alert.com) which is an option flow aggregation service I use on a daily basis. I have no horse in the TSLA race (plenty of other ways for me to make and lose money and sleep better at night), but it might...
by Bob von Halle | Jan 31, 2020 | Commentary, Options
Very heavy first hour call buying in Pfizer…..over 25,000 call options have been bought so far today. Specifically, over 11,000 of the regular February expiration $38.5 strike calls have traded most around the $.28-.30 level. See Doug’s earlier post on the...
by Bob von Halle | Jan 29, 2020 | Commentary, Options
Significant call option buying in Viacom CBS (VIAC) as the stock hits a new 52 week low. At $34.70, a buyer bought 3,600 June $40 calls at $.84 and then over 5,000 Sept. $42.5 calls traded around $.87. This is by far and away the cheapest name in the media universe,...
by Bob von Halle | Jan 28, 2020 | Commentary, Options
Have seen quite a pick up in option activity in recent days in Gilead Sciences (GILD). Yesterday over 10,000 March $67.5 calls were purchased at various prices up to $.95 (closed today at $1.10). Today, saw almost the same amount of the Jan 31st weekly $64.5 calls...
